claim: one art regimen tied to increased covid-19 risk in hiv
evidence_1: researchers estimated a risk for covid-19 diagnosis of 30.0 per 10.000 and 3.7 per 10,000 for death among hiv-positive people receiving art.", "risk of covid-19 diagnosis and hospitalization was lower for people living with hiv receiving truvada, or tenofovir disoproxil fumarate (tdf)/emtricitabine (ftc), compared with those on other art regimens, as well as the spanish population ages 20-79, reported julia del amo, md, phd, of the national plan against aids in madrid, and colleagues.", "moreover, the risk of covid-19 diagnosis was not higher among people living with hiv on art than the general population of spain, they wrote in the annals of internal medicine.", 
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  "\"the lack of increased risk for serious covid-19 among hiv-positive persons might be the result of their use of art,\" they wrote, adding art was proposed as a protective factor against sars in 2003, but there were too few cases to draw meaningful conclusions about its role.")